www.advansiv.net Open in urlscan Pro
2a02:26f0:64::210:6ad1  Public Scan

Submitted URL: https://rs.amerisourcebergen.advansiv.com/clk?params=gi4dgnbwg44taobsge3qcmjrgu4ac2duorydulzpo53xoltbmr3gc3ttnf3c43tfoqxwg3djmvxhi4zpmfrgg...
Effective URL: http://www.advansiv.net/clients/abc/HTML/2022/2022-11-ABC-New-Product-Launch-TAFLUPROST-DROP.htm?rs_oid_rd=283467908217
Submission: On November 28 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

New Product launch November 21, 2022

TAFLUPROST DROP

Supplier: Prasco Pronunciation: TA-floo-prost Compared to: Zioptan Rating: AT
Therapeutic class: Ophthalmic Preparations Exclusivity: No Authorized generic:
Prasco First to Shelf® auto-shipment: No 45-day brand to generic substitution:
No Expected in distribution centers: 11/22/2022

Please check your ordering system for pricing information.



ABC 8 NDC Description 10275003 66993042930 TAFLUPROST 0.0015% O/S 30X0.3 ML


AmerisourceBergen continually adds newly launched generics to the PRxO Generics
formulary. All PRxO Generics purchases count towards PRxO Generics compliance
and a majority of these purchases are eligible for PRxO Generics rebates. To
determine if a specific item is rebate eligible, please reference your PRxO
Generics contract in your ordering system. Non-rebatable items are priced to
provide you with meaningful on-invoice savings.

1. Confidential & proprietary information of AmerisourceBergen Corporation. 2.
Marks referenced herein may belong to entities other than AmerisourceBergen and
may be registered or otherwise protected. 3. Comparisons are based on FDA
determinations.



The AmerisourceBergen® logo, AmerisourceBergen® and PRxO Generics® First to
Shelf® are registered trademarks. Information contained in this document is
based on currently available manufacturer information and is subject to change
at any time based on market changes.

This email was sent by:
AmerisourceBergen
1300 Morris Drive, Chesterbrook, PA 19087
610.727.7000
http://www.amerisourcebergen.com

© 2022 AmerisourceBergen Corporation. All Rights Reserved.